Physician profile
Ted Williams
NPI 1346247137
$597.08
in general payments reported to CMS, 2019-2025
10 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $51.53 · 2021: $12.71 · 2022: $149 · 2023: $61.29 · 2024: $41.02 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $237.25 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $188.02 | 2022-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $35.40 | 2025 | |
| Seqirus USA INC | $32.50 | 2022-2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $19.50 | 2025 | Enflonsia, M-M-R II, Vaxelis |
| Acadia Pharmaceuticals INC | $19.24 | 2025 | Daybue |
| Supernus Pharmaceuticals, INC. | $18.97 | 2023 | Qelbree |
| Collegium Pharmaceutical, INC. | $16.81 | 2025 | Jornay Pm |
| Pfizer INC. | $16.68 | 2024 | |
| Nestle Healthcare Nutrition INC. | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.